A1AHK
N-{1-[(5-cyanopyridin-2-yl)methyl]-1H-pyrazol-3-yl}-2-{4-[1-(trifluoromethyl)cyclopropyl]phenyl}acetamide
Find entries where: A1AHK
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | N-{1-[(5-cyanopyridin-2-yl)methyl]-1H-pyrazol-3-yl}-2-{4-[1-(trifluoromethyl)cyclopropyl]phenyl}acetamide |
Identifiers | ~{N}-[1-[(5-cyanopyridin-2-yl)methyl]pyrazol-3-yl]-2-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]ethanamide |
Formula | C22 H18 F3 N5 O |
Molecular Weight | 425.406 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc(ccc1CC(=O)Nc2ccn(n2)Cc3ccc(cn3)C#N)C4(CC4)C(F)(F)F |
InChI | InChI=1S/C22H18F3N5O/c23-22(24,25)21(8-9-21)17-4-1-15(2-5-17)11-20(31)28-19-7-10-30(29-19)14-18-6-3-16(12-26)13-27-18/h1-7,10,13H,8-9,11,14H2,(H,28,29,31) |
InChIKey | LSYANGLAZUZYFX-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 49 |
Chiral Atom Count | 0 |
Bond Count | 52 |
Aromatic Bond Count | 17 |
Drug Info: DrugBank
DrugBank ID | DB16241 |
---|---|
Name | Apinocaltamide |
Groups | investigational |
Description | Apinocaltamide is under investigation in clinical trial NCT03239691 (A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients). |
Synonyms |
|
Categories |
|
CAS number | 1838651-58-3 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL4217292 |
PubChem | 118560618 |
ChEMBL | CHEMBL4217292 |
ChEBI | CHEBI:194340 |